CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.39
-0.35 (-3.26%)
Nov 21, 2024, 2:04 PM EST - Market open
CorMedix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 12.26 | - | 0.07 | 0.19 | 0.24 | 0.28 | Upgrade
|
| Revenue Growth (YoY) | 41184.20% | - | -65.74% | -20.19% | -15.55% | -34.09% | Upgrade
|
| Cost of Revenue | 2.01 | - | 0 | 0.15 | 0.2 | 0.37 | Upgrade
|
| Gross Profit | 10.25 | - | 0.06 | 0.04 | 0.03 | -0.09 | Upgrade
|
| Selling, General & Admin | 56.7 | 35.8 | 20.01 | 16.35 | 13.88 | 9.87 | Upgrade
|
| Research & Development | 4.5 | 13.16 | 10.68 | 13.13 | 13.38 | 11.05 | Upgrade
|
| Operating Expenses | 61.21 | 48.96 | 30.69 | 29.48 | 27.26 | 20.92 | Upgrade
|
| Operating Income | -50.96 | -48.96 | -30.62 | -29.44 | -27.22 | -21.01 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.03 | -0.02 | -0.03 | -0.79 | Upgrade
|
| Interest & Investment Income | 2.99 | 2.68 | 0.33 | 0.01 | 0.12 | 0.32 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.04 | -0.03 | 0.04 | -0.02 | -0.06 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.5 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -47.54 | -46.34 | -30.29 | -29.46 | -27.2 | -21.49 | Upgrade
|
| Pretax Income | -47.54 | -46.34 | -30.29 | -29.46 | -27.2 | -21.49 | Upgrade
|
| Income Tax Expense | -1.39 | - | -0.59 | -1.25 | -5.17 | -5.06 | Upgrade
|
| Net Income | -46.15 | -46.34 | -29.7 | -28.21 | -22.03 | -16.43 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 27.1 | Upgrade
|
| Net Income to Common | -46.15 | -46.34 | -29.7 | -28.21 | -22.03 | -43.54 | Upgrade
|
| Shares Outstanding (Basic) | 58 | 51 | 40 | 38 | 29 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 51 | 40 | 38 | 29 | 24 | Upgrade
|
| Shares Change (YoY) | 23.09% | 26.39% | 6.92% | 31.87% | 18.26% | 35.56% | Upgrade
|
| EPS (Basic) | -0.80 | -0.91 | -0.74 | -0.75 | -0.77 | -1.80 | Upgrade
|
| EPS (Diluted) | -0.80 | -0.91 | -0.74 | -0.75 | -0.77 | -1.80 | Upgrade
|
| Free Cash Flow | -56.15 | -38.74 | -24.58 | -22.58 | -22.08 | -15.09 | Upgrade
|
| Free Cash Flow Per Share | -0.97 | -0.76 | -0.61 | -0.60 | -0.77 | -0.62 | Upgrade
|
| Gross Margin | 83.57% | - | 94.29% | 22.00% | 14.37% | -31.76% | Upgrade
|
| Operating Margin | -415.59% | - | -46819.91% | -15417.51% | -11378.44% | -7416.31% | Upgrade
|
| Profit Margin | -376.35% | - | -45409.90% | -14774.70% | -9207.70% | -15369.18% | Upgrade
|
| Free Cash Flow Margin | -457.89% | - | -37573.53% | -11826.24% | -9229.69% | -5326.65% | Upgrade
|
| EBITDA | -50.77 | -48.89 | -30.54 | -29.38 | -27.09 | -20.93 | Upgrade
|
| D&A For EBITDA | 0.19 | 0.07 | 0.08 | 0.06 | 0.13 | 0.07 | Upgrade
|
| EBIT | -50.96 | -48.96 | -30.62 | -29.44 | -27.22 | -21.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.